The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids 175Boger DL, Miyauchi H, Hedrick MP (2001) Alpha-keto heterocycle inhibitors of fatty acid
amide hydrolase: carbonyl group modification and alpha-substitution. Bioorg Med
Chem Lett 11:1517–1520
Bornheim LM, Kim KY, Chen B, Correia MA (1993) The effect of cannabidiol on mouse
hepatic microsomal cytochrome P450-dependent anandamide metabolism. Biochem
Biophys Res Commun 197:740–746
Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF (2002) Structural adaptations
in a membrane enzyme that terminates endocannabinoid signaling. Science 298:1793–
1796
Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled
cannabinoid receptor in mouse brain. Mol Pharmacol 60:155–163
Brenowitz SD, Regehr WG (2003) Calcium dependence of retrograde inhibition by endo-
cannabinoids at synapses onto Purkinje cells. J Neurosci 23:6373–6384
BrooksJW,PryceG,BisognoT,JaggarSI,HankeyDJ,BrownP,BridgesD,LedentC,Bifulco
M, Rice AS, Di Marzo V, Baker D (2002) Arvanil-induced inhibition of spasticity and
persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1
receptor and cannabinoid CB(1)/CB(2) receptors. Eur J Pharmacol 439:83–92
Cadas H, di Tomaso E, Piomelli D (1997) Occurrence and biosynthesis of endogenous
cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J Neu-
rosci 17:1226–1242
Calignano A, La Rana G, Giuffrida A, Piomelli D (1998) Control of pain initiation by
endogenous cannabinoids. Nature 394:277–281
Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Camp-
bell WB, Hillard CJ (2004) Cultured rat microglial cells synthesize the endocannabi-
noid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent
mechanism. Mol Pharmacol 65:999–1007
Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huff-
manJW,JorcanoJL,GuzmanM(2003)Inhibitionofskintumorgrowthandangiogenesis
in vivo by activation of cannabinoid receptors. J Clin Invest 111:43–50
Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P (2001) Direct inhibition of T-type
calcium channels by the endogenous cannabinoid anandamide. EMBO J 20:7033–7040
Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses:
a novel role of endocannabinoids in regulating excitability. Neuron 38:461–472
Clement AB, Hawkins EG, Lichtman AH, Cravatt BF (2003) Increased seizure susceptibility
and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase.
J Neurosci 23:3916–3923
Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, Auer D, Yassouridis
A, Thone-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC,
Pasquali R, Lutz B, Stalla GK, Pagotto U (2003) The endogenous cannabinoid system
affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin
Invest 112:423–431
Craib SJ, Ellington HC, Pertwee RG, Ross, RA (2001) A possible role of lipoxygenase in
the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br
J Pharmacol 134:30–37
Cravatt BF, Lichtman AH (2003) Fatty acid amide hydrolase: an emerging therapeutic target
in the endocannabinoid system. Curr Opin Chem Biol 7:469–475
Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular
characterizationofanenzymethatdegradesneuromodulatoryfatty-acidamides.Nature
384:83–87
CravattBF,DemarestK,PatricelliMP,BraceyMH,GiangDK,MartinBR,LichtmanAH(2001)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in
mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98:9371–9376
de Lago E, Fernandez-Ruiz J, Ortega-Gutierrez S, Viso A, Lopez-Rodriguez ML, Ramos JA
(2002) UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates
hypokinetic and antinociceptive effects of anandamide. Eur J Pharmacol 449:99–103